Switchable gene drives

可切换基因驱动

基本信息

  • 批准号:
    BB/P009506/1
  • 负责人:
  • 金额:
    $ 76.28万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2017
  • 资助国家:
    英国
  • 起止时间:
    2017 至 无数据
  • 项目状态:
    已结题

项目摘要

Research and biotechnology often require that proteins are switched on or off within living organisms, to understand or manipulate their function. In this proposal, we describe how proteins can be rapidly switched on using the mouse as a model system. As a proof-of-principle, we have selected the gene drive, where tight regulation is essential and a switching mechanism would be extremely advantageous. Gene drives duplicate a segment of the genome whether or not they confer any selective advantage and in principle work in any sexually reproducing species so that all offspring inherit the genome segment that is part of the gene drive. The potential of gene drives to combat disease, foster sustainable agriculture and eradicate invasive pests has been widely recognised. However, given their potential to do harm as well as good, gene drives have provoked concerns about their reversibility and control.Here, we propose a switchable protein system that gives exquisitely tight control of a gene drive in mice. We describe a switchable system that can be controlled by the addition of a synthetic amino acid, BOC, not found in mammals. We have already engineered the basics of this system to contain a non-mammalian aminoacyl-tRNA synthetase enzyme so that it adds BOC to a non-mammalian tRNA. This tRNA recognises a stop codon, so that when BOC is present it is incorporated into the target protein at a position that otherwise causes protein synthesis to terminate: in other words, BOC switches production of the protein on. The switchable synthetic protein system works well in cultured mammalian cells but has never been reported in living vertebrates.In a pilot study, we are applying this system to switch on the expression of a fluorescent protein in mice so that they contain fluorescent cells only when their food includes BOC. Although these experiments are preliminary, they have encouraged us to extend our work to gene drives. As containment is a major concern in work on gene drives, development of a gene drive system lends itself well to our proposed mouse model; the mouse minimises containment issues and will have broad and direct research, biomedical and agricultural applications.Our approach will use a specific protein to execute the gene drives. Using a cell culture system, we will identify mutants of the protein that remain active when they contain BOC. This information will also allow us to produce active proteins containing 2 or 3 BOC residues. The genes required for this switchable system will then be introduced into the mouse genome; the system will be set up so that the genes are active only at the time of fertilisation. Our goal here will be to confirm the switchability of the system by showing that functional BOC mutant proteins are only present at the time of fertilisation and when BOC is present in feed or drinkwater.Based on our pilot study, we are confident of success that will lead to the test of a gene drive using the tyrosinase gene, Tyr. Mice with one or two Tyr genes have a black coat colour; those with no Tyr genes (for example, because they are removed by a gene drive) are white. In our experiment, if BOC is absent from the feed (as normal), the offspring are black, but if it is included, they should be white, providing a clear test of whether the inducible gene drive worked.The proposed work aligns with BBSRC strategic priorities in synthetic biology and technology development for biosciences. Application of this system is not restricted to given proteins and may lead to safeguards in pathogen research and artificial protein regulation for developmental analysis. It constitutes a tractable system for transgenerational genome modification that promises to have applications in plants, insects and other animals, including streamlining the generation of disease-resistant livestock.
研究和生物技术通常需要在生物体内打开或关闭蛋白质,以了解或操纵它们的功能。在这个提议中,我们描述了如何使用小鼠作为模型系统快速打开蛋白质。作为原理证明,我们选择了基因驱动,其中严格的调控是必不可少的,开关机制将是非常有利的。基因驱动复制基因组的一个片段,无论它们是否赋予任何选择性优势,原则上在任何有性繁殖的物种中起作用,以便所有后代继承作为基因驱动一部分的基因组片段。基因驱动在防治疾病、促进可持续农业和根除入侵害虫方面的潜力已得到广泛认可。然而,考虑到它们的潜在危害以及良好的,基因驱动引起了人们对它们的可逆性和控制的担忧。在这里,我们提出了一种可切换的蛋白质系统,它可以精确地控制小鼠的基因驱动。我们描述了一个可切换的系统,可以通过添加合成的氨基酸,BOC,没有发现在哺乳动物中控制。我们已经设计了这个系统的基础,使其包含非哺乳动物氨酰-tRNA合成酶,以便将BOC添加到非哺乳动物tRNA上。该tRNA识别终止密码子,因此当BOC存在时,它被掺入靶蛋白的一个位置,否则会导致蛋白质合成终止:换句话说,BOC可以打开蛋白质的生产。这种可转换的合成蛋白质系统在培养的哺乳动物细胞中工作良好,但在活的脊椎动物中从未报道过。在一项初步研究中,我们正在应用这个系统来启动小鼠体内荧光蛋白的表达,这样它们只有在食物中含有BOC时才含有荧光细胞。虽然这些实验是初步的,但它们鼓励我们将我们的工作扩展到基因驱动。由于基因驱动工作的主要关注点是遏制,因此基因驱动系统的开发非常适合我们提出的小鼠模型;小鼠最大限度地减少了遏制问题,并将具有广泛和直接的研究,生物医学和农业应用。我们的方法将使用特定的蛋白质来执行基因驱动。使用细胞培养系统,我们将确定突变的蛋白质,保持活性时,他们含有BOC。这些信息也将使我们能够生产含有2或3个BOC残基的活性蛋白质。这个可转换系统所需的基因将被引入小鼠基因组中;该系统将被设置为使基因仅在受精时活跃。我们的目标是通过证明功能性BOC突变蛋白仅在受精时以及BOC存在于饲料或饮用水中时存在来确认系统的可切换性。基于我们的初步研究,我们有信心成功测试使用酪氨酸酶基因Tyr的基因驱动。有一个或两个Tyr基因的小鼠有黑色的毛色;没有Tyr基因的小鼠(例如,因为它们被基因驱动删除)是白色。在我们的实验中,如果饲料中没有BOC(正常情况下),后代是黑色的,但如果包含BOC,它们应该是白色的,这为诱导型基因驱动是否有效提供了明确的测试。拟议的工作符合BBSRC在合成生物学和生物科学技术开发方面的战略重点。该系统的应用不限于给定的蛋白质,并可能导致在病原体研究和人工蛋白质调控发育分析的保障。它构成了一个易于处理的跨代基因组修改系统,有望在植物、昆虫和其他动物中得到应用,包括简化抗病牲畜的生产。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A program of successive gene expression in mouse one-cell embryos
  • DOI:
    10.1016/j.celrep.2023.112023
  • 发表时间:
    2023-01-31
  • 期刊:
  • 影响因子:
    8.8
  • 作者:
    Asami, Maki;Lam, Brian Y. H.;Perry, Anthony C. F.
  • 通讯作者:
    Perry, Anthony C. F.
Development of mammalian cell logic gates controlled by unnatural amino acids.
  • DOI:
    10.1016/j.crmeth.2021.100073
  • 发表时间:
    2021-10-25
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Human embryonic genome activation initiates at the one-cell stage.
  • DOI:
    10.1016/j.stem.2021.11.012
  • 发表时间:
    2022-02-03
  • 期刊:
  • 影响因子:
    23.9
  • 作者:
    Asami M;Lam BYH;Ma MK;Rainbow K;Braun S;VerMilyea MD;Yeo GSH;Perry ACF
  • 通讯作者:
    Perry ACF
Genomic imprinting in mouse blastocysts is predominantly associated with H3K27me3.
  • DOI:
    10.1038/s41467-021-23510-4
  • 发表时间:
    2021-06-21
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Santini L;Halbritter F;Titz-Teixeira F;Suzuki T;Asami M;Ma X;Ramesmayer J;Lackner A;Warr N;Pauler F;Hippenmeyer S;Laue E;Farlik M;Bock C;Beyer A;Perry ACF;Leeb M
  • 通讯作者:
    Leeb M
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anthony Perry其他文献

Role models’ influence on student interest in and awareness of career opportunities in life sciences
榜样对学生对生命科学职业机会的兴趣和意识的影响
The Tissue Systems Pathology Test Outperforms Pathology Review in Risk Stratifying Patients With Low-Grade Dysplasia
组织系统病理学检测在低级别不典型增生患者的风险分层中优于病理学回顾
  • DOI:
    10.1053/j.gastro.2023.07.029
  • 发表时间:
    2023-11-01
  • 期刊:
  • 影响因子:
    25.100
  • 作者:
    Amir M. Khoshiwal;Nicola F. Frei;Roos E. Pouw;John Goldblum;Elizabeth Montgomery;Jon Davison;Jagjit Singh;Jared Szymanski;Anthony Perry;Kees Seldenrijk;Fiebo ten Kate;G. Johan A. Offerhaus;Paul Drillenberg;Casper Jansen;Natalja Leeuwis-Fedorovic;Runjan Chetty;Roger Feakins;Marnix Jansen;Catherine Chinyama;Edwin Cooper;Jacques J.G.H.M. Bergman
  • 通讯作者:
    Jacques J.G.H.M. Bergman
Minimising RF Detectability for Low Probability of Detection Communication
最大限度地减少射频可检测性,以实现低概率的检测通信
Ravos : Exercising Contextually Aware Distributed Autonomic Control in Land Vehicles
Ravos:在陆地车辆中实施情境感知分布式自主控制
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Benjamin Campbell;G. Pearce;Anthony Perry;B. Sims;Mohammad Zamani;Lance Newby;R. Hunjet
  • 通讯作者:
    R. Hunjet
The Influence of Stall Distance on Effective Shepherding of a Swarm
失速距离对蜂群有效牧养的影响
  • DOI:
    10.1007/978-3-030-60898-9_4
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Anthony Perry
  • 通讯作者:
    Anthony Perry

Anthony Perry的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anthony Perry', 18)}}的其他基金

New embryological perspectives on imprinting disease
关于印记疾病的新胚胎学观点
  • 批准号:
    MR/W024845/1
  • 财政年份:
    2022
  • 资助金额:
    $ 76.28万
  • 项目类别:
    Research Grant
Novel homology-directed gene targeting to enhance biomedical modeling
新型同源基因靶向增强生物医学模型
  • 批准号:
    MR/N020294/1
  • 财政年份:
    2016
  • 资助金额:
    $ 76.28万
  • 项目类别:
    Research Grant
Delineating the roles of NSun proteins at the onset of mouse embryogenesis
描述 NSun 蛋白在小鼠胚胎发生开始时的作用
  • 批准号:
    MR/N000080/1
  • 财政年份:
    2015
  • 资助金额:
    $ 76.28万
  • 项目类别:
    Research Grant
Mammalian sperm-borne DNA binding proteins as reprogramming factors
哺乳动物精子携带的 DNA 结合蛋白作为重编程因子
  • 批准号:
    G1000839/1
  • 财政年份:
    2011
  • 资助金额:
    $ 76.28万
  • 项目类别:
    Research Grant
U.S.-Australia Workshop on Critical Issues in High Performance Wear Resistant Films/Sydney, Australia/February 1995
美国-澳大利亚高性能耐磨薄膜关键问题研讨会/澳大利亚悉尼/1995 年 2 月
  • 批准号:
    9417020
  • 财政年份:
    1995
  • 资助金额:
    $ 76.28万
  • 项目类别:
    Standard Grant

相似国自然基金

Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
  • 批准号:
    82371801
  • 批准年份:
    2023
  • 资助金额:
    47.00 万元
  • 项目类别:
    面上项目
Pik3r2基因突变在家族内侧颞叶癫痫中的作用及发病机制研究
  • 批准号:
    82371454
  • 批准年份:
    2023
  • 资助金额:
    47.00 万元
  • 项目类别:
    面上项目
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
  • 批准号:
    82371141
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
发展基因编码的荧光探针揭示趋化因子CXCL10的时空动态及其调控机制
  • 批准号:
    32371150
  • 批准年份:
    2023
  • 资助金额:
    50.00 万元
  • 项目类别:
    面上项目
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
  • 批准号:
    82370906
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目
lncGEI诱导湖羊卵巢颗粒细胞E2合成的分子机制
  • 批准号:
    32372856
  • 批准年份:
    2023
  • 资助金额:
    50.00 万元
  • 项目类别:
    面上项目
RET基因634位点不同氨基酸改变对甲状腺C细胞的影响与机制研究
  • 批准号:
    82370790
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
KMT2A基因突变通过DNMT3靶向调控GBP2导致神经发育障碍的机制研究
  • 批准号:
    82371867
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
综合医疗机构引入Gene-Xpert MTB/RIF技术早期发现传染性肺结核和耐药肺结核的研究
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
Brahma related gene 1/Lamin B1通路在糖尿病肾脏疾病肾小管上皮细胞衰老中的作用
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目

相似海外基金

MLL1 drives collaborative leukocyte-endothelial cell signaling and thrombosis after coronavirus infection
MLL1在冠状病毒感染后驱动白细胞-内皮细胞信号传导和血栓形成
  • 批准号:
    10748433
  • 财政年份:
    2023
  • 资助金额:
    $ 76.28万
  • 项目类别:
Targeting the oncoprotein that drives FLC
靶向驱动 FLC 的癌蛋白
  • 批准号:
    10902751
  • 财政年份:
    2023
  • 资助金额:
    $ 76.28万
  • 项目类别:
NCAM drives synaptic remodeling in developing GABAergic neurons in C. elegans
NCAM 驱动线虫发育中 GABA 能神经元的突触重塑
  • 批准号:
    10752458
  • 财政年份:
    2023
  • 资助金额:
    $ 76.28万
  • 项目类别:
Glutamatergic plasticity that drives cannabinoid withdrawal and craving
谷氨酸可塑性导致大麻素戒断和渴望
  • 批准号:
    10743526
  • 财政年份:
    2023
  • 资助金额:
    $ 76.28万
  • 项目类别:
A Trim28-ERV axis drives phenotypic variation in obesity
Trim28-ERV 轴驱动肥胖的表型变异
  • 批准号:
    10586530
  • 财政年份:
    2023
  • 资助金额:
    $ 76.28万
  • 项目类别:
Altered miRNA Expression Drives Proliferation of Lymphatic Malformation by Activating Pro-Growth Signaling Cascades
改变的 miRNA 表达通过激活促生长信号级联驱动淋巴畸形的增殖
  • 批准号:
    10677332
  • 财政年份:
    2023
  • 资助金额:
    $ 76.28万
  • 项目类别:
IL17 dependent angiocrine signaling drives inflammation in alcohol associated hepatitis
IL17 依赖性血管分泌信号传导驱动酒精相关性肝炎的炎症
  • 批准号:
    10837927
  • 财政年份:
    2023
  • 资助金额:
    $ 76.28万
  • 项目类别:
p27pTpT drives cancer-promoting inflammation and shapes the tumor microenvironment (TME) toward a more tumor-permissive state in vivo
p27pTpT 驱动促癌炎症,并将肿瘤微环境 (TME) 塑造为更适合体内肿瘤生长的状态
  • 批准号:
    10744370
  • 财政年份:
    2023
  • 资助金额:
    $ 76.28万
  • 项目类别:
MYCN drives a ferroptotic vulnerability in neuroblastoma
MYCN 导致神经母细胞瘤铁死亡的脆弱性
  • 批准号:
    10736479
  • 财政年份:
    2023
  • 资助金额:
    $ 76.28万
  • 项目类别:
Defining molecular mechanisms by which stimulant evoked dopamine drives inflammation and neuronal dysfunction in neuroHIV
定义兴奋剂诱发多巴胺驱动神经艾滋病毒炎症和神经元功能障碍的分子机制
  • 批准号:
    10685160
  • 财政年份:
    2023
  • 资助金额:
    $ 76.28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了